COST-EFFECTIVENESS OF LEVETIRACETAM FOR PATIENTS WITH JUVENILE MYOCLONIC EPILEPSY: A MODELING APPROACH BY THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

被引:0
|
作者
Kayo, M. [1 ]
Rosim, R. P. [2 ]
Duva, A. [2 ]
Ballalai Ferraz, A. F. [2 ]
Carmo, E. [1 ]
机构
[1] UCB Biopharma LTDA, Sao Paulo, Brazil
[2] QuintilesIMS, Sao Paulo, Brazil
关键词
D O I
10.1016/j.jval.2017.08.1944
中图分类号
F [经济];
学科分类号
02 ;
摘要
PND30
引用
收藏
页码:A722 / A723
页数:2
相关论文
共 50 条
  • [1] Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
    Cazarim, Maurilio de Souza
    Vilela Rodrigues, Joao Paulo
    Coelho da Cruz-Cazarim, Estael Luzia
    Ayres, Lorena Rocha
    Leira Pereira, Leonardo Regis
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (03)
  • [2] COST-EFFECTIVENESS OF BREECH VERSION BY MOXIBUSTION ASSOCIATED WITH ACUPUNCTURE FOR WOMEN AT 33 WEEKS GESTATION: A MODELING APPROACH BY THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Rosim, R. P.
    Carmo, E., V
    VALUE IN HEALTH, 2017, 20 (09) : A924 - A924
  • [3] Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
    Cazarim, Maurilio de Souza
    Leira Pereira, Leonardo Regis
    PLOS ONE, 2018, 13 (03):
  • [4] Cost-effectiveness and Price of Aripiprazole for Schizophrenia in the Brazilian Public Health System
    Santos, Andre Soares
    Micaela de Souza Noronha, Kenya Valeria
    Andrade, Monica Viegas
    Ruas, Cristina Mariano
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2020, 23 (01): : 27 - 37
  • [5] COST-EFFECTIVENESS OF DULOXETINE COMPARED TO PREGABALINE IN PATIENTS WITH FIBROMYALGIA FROM THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN MEXICO
    Ramirez-Gamez, J.
    Duenas-Tentori, H.
    VALUE IN HEALTH, 2011, 14 (07) : A563 - A563
  • [6] COST-EFFECTIVENESS OF CINACALCET CHRONIC KIDNEY DISEASE PATIENTS ON DIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
    Nishikawa, A. M.
    Coutinho, M. B.
    Custodio, M. R.
    Pecoits-Filho, R. F.
    Clark, O. A. C.
    VALUE IN HEALTH, 2013, 16 (07) : A698 - A698
  • [7] Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective
    Zanghelini, Fernando
    de Oliveira Jr, Haliton Alves
    Castano Silva, Thales Brendon
    Pereira, Daniel da Silva
    Araujo de Oliveira, Gustavo Laine
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 85 - 92
  • [8] Cost-effectiveness of saxaglipitin in the Brazilian supplementary health system
    de Oliveira, Italo Martins
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2013, 59 (02): : 101 - 101
  • [9] COST-EFFECTIVENESS OF MYCOPHELONATE SODIUM ON PATIENTS WITH RENAL TRANSPLANT AT THE PUBLIC MEXICAN HEALTH CARE SYSTEM
    Miranda, Ruiz C., I
    Lopez, Ubiarco, V
    VALUE IN HEALTH, 2014, 17 (07) : A469 - A470
  • [10] COST-EFFECTIVENESS ANALYSIS OF THE ASPERGILLUS GALACTOMANNAN ENZYME IMMUNOASSAY IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Barros, B.
    Magliano, C.
    Morais, Q. C.
    Leite, B. R.
    Leite, L. F. D. A.
    Mateus, I
    Braga, A.
    Santos, M.
    VALUE IN HEALTH, 2023, 26 (06) : S62 - S62